Healthcare Services Group, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HCSG research report →
Range $24 – $30
Price Chart
About the company
Healthcare Services Group, Inc. , established in 1976 and based in Bensalem, Pennsylvania, provides outsourced management and operational services to healthcare and senior living facilities nationwide. The company supports departments such as housekeeping, laundry, facility maintenance, and dietary services for clients including nursing homes, retirement complexes, rehabilitation centers, and hospitals.
- CEO
- Theodore Wahl
- IPO
- 1983
- Employees
- 36,000
- HQ
- Bensalem, PA, US
Get TickerSpark's AI analysis on HCSG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $1.67B
- P/E
- 16.62
- Fwd P/E
- 18.49
- PEG
- 0.09
- P/S
- 0.90
- P/B
- 3.21
- EV/EBITDA
- 11.77
- Div Yield
- 0.00%
- Gross Margin
- 16.34%
- Op Margin
- 6.04%
- Net Margin
- 5.58%
- ROE
- 20.22%
- ROIC
- 14.31%
Latest fiscal year · YoY change
- Revenue
- $1.84B+7.1%
- Gross Profit
- $239.41M+5.0%
- Op Income
- $48.54M
- Net Income
- $59.06M+49.6%
- EPS
- $0.82+51.9%
- OCF Growth
- +370.6%
- FCF Growth
- +468.7%
- 52W High
- $27.05
- 52W Low
- $16.78
- 50D MA
- $22.78
- 200D MA
- $21.84
- Beta
- 0.81
- RSI (14)
- 58
- Avg Volume
- 684.69K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Healthcare Services Group posted a solid Q3 with revenue growth, better-than-target margins, and raised its 2027 revenue outlook after adding NEXDINE.· October 21, 2026
- Q3 revenue was $479.6 million, with net income of $24.9 million and diluted EPS of $0.36.
- Cost of services was 83.2%, better than the 86% long-term target, helped by service execution and lower bad debt.
- The company raised its 2027 revenue growth outlook to low double digits from mid-single digits and guided Q4 revenue to $535 million-$545 million.
- NEXDINE Hospitality was acquired on October 6 and is expected to add over $150 million in annual revenue at comparable margins and be immediately accretive to earnings.
- Cash and marketable securities were $204.3 million, and the company had an unutilized $300 million credit facility; it repurchased $11.7 million of stock in Q3.
Revenue was $479.6 million. Environmental Services revenue was $217.2 million with a 13.3% margin, and Dietary Services revenue was $262.4 million with an 8.7% margin. Cost of services was $399.2 million, or 83.2%, and SG&A was $48.5 million; adjusted SG&A was $49.1 million, or 10.2%. Net income was $24.9 million and diluted EPS was $0.36. Cash flow from operations was $30.2 million; adjusted for a $9.5 million decrease in the payroll accrual, it was $20.7 million. As of quarter-end, cash and marketable securities were $204.3 million, with an unutilized $300 million credit facility. The company guided Q4 revenue to $535 million-$545 million and raised 2027 revenue growth outlook to low double digits. Management said the $6.1 million Genesis recovery flows through the P&L as a bad debt offset, and it expects the 2026 effective tax rate to be approximately 25%.
Ted Wahl framed the quarter as evidence of strong fundamentals, saying new client wins, high retention, and operational execution drove the ninth sequential revenue increase over the past 10 quarters. He was upbeat on the industry backdrop, pointing to a multi-decade demographic tailwind in senior care, and said the company is well positioned across healthcare, senior living, and campus end markets. His tone was confident on growth, especially after the NEXDINE acquisition and the raised 2027 outlook.
Vikas Singh focused on liquidity, cash flow, and capital returns. He highlighted $204.3 million of cash and marketable securities, an unutilized $300 million revolver, and $11.7 million of share repurchases in Q3, bringing year-to-date buybacks to $56.6 million with 7.7 million shares remaining under authorization. He also noted the Genesis-related $6.1 million recovery was a bad debt offset flowing through the P&L, and said NEXDINE is expected to be accretive even after losing interest income on roughly $90 million-$100 million of cash used in the deal.
Analysts focused on whether 2027 low-double-digit revenue growth implies faster organic growth, and management said the outlook includes mid-single-digit organic growth plus NEXDINE, with timing influenced by management capacity and client start-date preferences. Questions also centered on Genesis recovery, bad debt, and the cost-of-services target; management said bad debt was about $2.5 million net of the Genesis benefit and that the 86% cost-of-services goal still makes sense because workers' comp and bad debt can be lumpy. On NEXDINE, management said integration is already underway, the business is similar in margin profile, and they expect it to be a double-digit growth opportunity, but they did not provide detailed numbers yet for intangibles or earn-out accounting.
The call showed accelerating top-line momentum, with management calling out a ninth sequential revenue increase and strong retention plus a solid pipeline. Margins were better than target, bad debt was unusually low, and the NEXDINE acquisition adds a new growth platform expected to be immediately accretive and to contribute over $150 million in annual revenue.
Management acknowledged that growth depends partly on management capacity, client start-date timing, and continued execution, so the organic acceleration is not guaranteed. They also emphasized that bad debt and workers' comp can be lumpy, and Genesis-related recoveries remain uncertain beyond the $6.1 million already recorded because final claim resolution timing and amounts are still TBD.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 98.9%
- Shares Outstanding
- 67.43M
- Float Shares
- 66.67M
of shares held by institutions
278 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for HCSG, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Greg GianforteHouse · MT00 | Buy | Apr 30, 20 | Filing → |
| Donna ShalalaHouse · FL27 | Sell | Jun 24, 19 | Filing → |
| Greg GianforteHouse · MT00 | Buy | Oct 11, 19 | Filing → |
| Greg GianforteHouse · MT00 | Sell | Sep 10, 19 | Filing → |
| Gilbert CisnerosHouse · CA39 | Sell | May 2, 19 | Filing → |
| Gilbert CisnerosHouse · CA39 | Sell | Mar 21, 19 | Filing → |
| Carlos CurbeloHouse · FL26 | Buy | Aug 28, 18 | Filing → |
| Thomas Roland TillisSenate · NC | Sell | Feb 13, 15 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 11.38M | ▼ 83.23K |
| Vanguard Group Inc | 8.04M | ▲ 1.48K |
| Vanguard Portfolio Management LLC | 5.08M | ▲ 234.18K |
| American Century Companies Inc | 3.31M | ▲ 645.01K |
| Vanguard Capital Management LLC | 3.04M | ▼ 79.17K |
| State Street Corp | 2.78M | ▼ 132.56K |
| Geode Capital Management, LLC | 2.56M | ▼ 6.65K |
| Dimensional Fund Advisors LP | 2.53M | ▲ 44.77K |
| Ameriprise Financial Inc | 2.26M | ▲ 89.45K |
| Royce & Associates LP | 1.98M | ▼ 256.54K |
| 8 Knots Management, LLC | 1.59M | ▼ 1.77M |
| Arrowstreet Capital, Limited Partnership | 1.44M | ▲ 37.10K |
Held by 347 ETFs
Biggest fund positions in HCSG by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 26, 26 | Bundick Jason J | sell | 18,239 |
| Sep 30, 26 | Grant Laura K | other | 367 |
| Sep 30, 26 | Simmons Kurt JR | other | 734 |
| Sep 30, 26 | WHALEN THOMAS GERARD | other | 123 |
| Aug 4, 26 | Kush Andrew | sell | 15,598 |
| Jul 1, 26 | Brophy Andrew M | other | 4,381 |
| Jun 30, 26 | Grant Laura K | other | 306 |
| Jun 30, 26 | WHALEN THOMAS GERARD | other | 102 |
| Jun 30, 26 | Simmons Kurt JR | other | 611 |
| May 27, 26 | Singh Vikas | other | 2,202 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HCSG coverage
Recent articles, reports, and earnings notes.
No research on HCSG yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HCSG report →Healthcare Services Group, Inc. (NASDAQ:HCSG) Stock Has Average Target Price of $26.67 According to Analysts
defenseworld.net · Nov 11
Healthcare Services Group, Inc. (HCSG) Soars to 52-Week High, Time to Cash Out?
zacks.com · Nov 3
Buy These 5 Top-Ranked Stocks With Superior Financial Efficiency
zacks.com · Oct 30
HCSG Q3 Earnings Call Highlights Higher 2027 Growth Outlook
zacks.com · Oct 28
Healthcare Services Group Is Cleaning Up, But It's Not Ready For Another Upgrade
seekingalpha.com · Oct 26
Is Healthcare Services (HCSG) a Solid Growth Stock? 3 Reasons to Think "Yes"
zacks.com · Oct 26
Earnings Estimates Moving Higher for Healthcare Services (HCSG): Time to Buy?
zacks.com · Oct 26
Healthcare Services (HCSG) Is Up 2.62% in One Week: What You Should Know
zacks.com · Oct 23
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.